Affinage

KCNAB3

Voltage-gated potassium channel subunit beta-3 · UniProt O43448

Length
404 aa
Mass
43.7 kDa
Annotated
2026-06-10
11 papers in source corpus 4 papers cited in narrative 4 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 2/2 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

KCNAB3 encodes Kvβ3, an auxiliary subunit that associates with Kv1-family voltage-gated potassium channel α-subunits and confers fast (A-type) inactivation: coexpression of Kvβ3.1 with the Kv1.5 α-subunit in CHO cells generates a novel, very fast-inactivating outward potassium current upon depolarization (PMID:9857044). A disease-linked missense mutation, H258R, identified in a family with genetic epilepsy with febrile seizures plus, accelerates channel inactivation and reduces potassium current when the mutant Kvβ3 is co-expressed with Kv1.1 in HEK293 cells (PMID:32990398), and a CRISPR/Cas9 knock-in of this mutation into mouse Kcnab3 reduces native potassium currents in hippocampal CA1 pyramidal neurons, establishing that KCNAB3 dysfunction impairs neuronal Kv channel function in the mammalian brain (PMID:36345448). Beyond these findings on subunit assembly, inactivation gating, and the H258R epilepsy link, no further mechanistic detail has been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 4 steps
  1. 1998 High

    Established that Kvβ3 is not merely a binding partner but a functional modulator that imposes a distinct gating behavior on Kv1 channels, answering what Kvβ3 does to channel function.

    Evidence Heterologous coexpression of Kvβ3.1 with Kv1.5 in CHO cells with electrophysiology

    PMID:9857044

    Open questions at the time
    • Tested only with Kv1.5; range of Kv1 α-partners not mapped
    • Structural basis of inactivation conferral not defined
    • No native-tissue confirmation of the Kvβ3/Kv1.5 pairing
  2. 2017 Medium

    Addressed whether Kvβ3 is a physiologically relevant Kv1.5 partner in vascular smooth muscle, finding it expressed at transcript level but not the predominant sarcolemmal partner.

    Evidence RT-qPCR, in situ proximity ligation assay, membrane fractionation and confocal microscopy in murine coronary arterial myocytes

    PMID:28342889

    Open questions at the time
    • Kvβ3 protein not detected at the protein level
    • No direct functional role established for Kvβ3 in this tissue
    • Kvβ1 and Kvβ2 dominate, leaving Kvβ3's native context unresolved
  3. 2020 Medium

    Connected KCNAB3 to human disease by showing a GEFS+-associated H258R mutation alters channel gating, linking a specific variant to a heritable epilepsy phenotype.

    Evidence Whole-exome sequencing and patch clamp of mutant Kvβ3(H258R) co-expressed with Kv1.1 in HEK293 cells

    PMID:32990398

    Open questions at the time
    • Single family, single lab; no mutagenesis rescue control
    • Mechanism by which H258R accelerates inactivation not defined at the structural level
    • Tested with Kv1.1 only
  4. 2022 Medium

    Tested whether the H258R effect holds in native mammalian neurons, confirming the mutation reduces potassium currents in hippocampal CA1 pyramidal cells in vivo.

    Evidence CRISPR/Cas9 H258R knock-in mouse with patch clamp of hippocampal CA1 pyramidal neurons

    PMID:36345448

    Open questions at the time
    • Effect limited across voltage range (no change at +80 mV)
    • No pharmacological or molecular rescue
    • Behavioral/seizure phenotype link to the current change not established here

Open questions

Synthesis pass · forward-looking unresolved questions
  • The full repertoire of native Kv1 α-partners for Kvβ3 across tissues and the structural/biochemical mechanism by which Kvβ3 (and the H258R variant) accelerates inactivation remain undefined.
  • No structural model of the Kvβ3/Kv1 complex
  • Native neuronal α-subunit partners not directly identified
  • Mechanistic basis of inactivation gating by Kvβ3 unresolved

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098772 molecular function regulator activity 2
Localization
GO:0005886 plasma membrane 1
Pathway
R-HSA-112316 Neuronal System 2
Partners

Evidence

Reading pass · 4 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1998 Human Kvβ3.1 (encoded by KCNA3B/KCNAB3) coexpressed with Kv1.5 α-subunit in CHO cells generates a novel A-type (very fast-inactivating) outward potassium current upon depolarization, demonstrating that Kvβ3.1 confers fast inactivation on the Kv1.5 channel. Heterologous coexpression in Chinese hamster ovary (CHO) cells; electrophysiology The Journal of biological chemistry High 9857044
2017 KVβ3 (AKR6A9/KCNAB3) transcript is expressed in murine coronary arteries, and in situ proximity ligation assays confirm protein-protein interactions between KV1.5 and KVβ proteins in coronary arterial myocytes; however, the predominant functional partners at the sarcolemma were KVβ1 and KVβ2, not KVβ3. RT-qPCR, Western blot, in situ proximity ligation assay, confocal microscopy, membrane fractionation Chemico-biological interactions Medium 28342889
2020 A novel missense mutation H258R in KCNAB3 (p.H258R, c.773A>G) was identified in a GEFS+ family; functional verification in HEK293 cells co-expressing Kvβ3(H258R) and Kv1.1 showed accelerated inactivation of potassium channels and reduced potassium current, increasing predicted neuronal excitability. Whole-exome sequencing, Sanger validation, electrophysiology (patch clamp) in HEK293 cells co-expressing mutant Kvβ3 and Kv1.1 Brain and behavior Medium 32990398
2022 Introduction of the human KCNAB3 H258R mutation into mouse KCNAB3 via CRISPR/Cas9 knock-in reduced total potassium currents in hippocampal CA1 pyramidal neurons (except at maximum voltage +80 mV), confirming the mutation impairs native neuronal Kv channel function in the mammalian brain. CRISPR/Cas9 knock-in mouse model; patch clamp electrophysiology of hippocampal CA1 pyramidal cells Translational pediatrics Medium 36345448

Source papers

Stage 0 corpus · 11 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1998 Coexpression of the KCNA3B gene product with Kv1.5 leads to a novel A-type potassium channel. The Journal of biological chemistry 60 9857044
2015 DNA methylation markers for oral pre-cancer progression: A critical review. Oral oncology 50 26690652
2018 Tracking age-correlated DNA methylation markers in the young. Forensic science international. Genetics 41 29933125
2012 Identification of novel genes involved in migraine. Headache 30 23030542
2016 PreImplantation factor prevents atherosclerosis via its immunomodulatory effects without affecting serum lipids. Thrombosis and haemostasis 26 26842698
2017 Heteromeric complexes of aldo-keto reductase auxiliary KVβ subunits (AKR6A) regulate sarcolemmal localization of KV1.5 in coronary arterial myocytes. Chemico-biological interactions 20 28342889
2017 Exploring genome-wide DNA methylation patterns in Aicardi syndrome. Epigenomics 7 28967789
2020 H258R mutation in KCNAB3 gene in a family with genetic epilepsy and febrile seizures plus. Brain and behavior 6 32990398
2025 A novel signature of cartilage aging-related immunophenotyping biomarkers in osteoarthritis. Computers in biology and medicine 3 39938337
2023 Comprehensive analysis of circRNA-miRNA-mRNA networks in the kidney of snakehead (Channa argus) response to Nocardia seriolae challenge. Developmental and comparative immunology 1 38007095
2022 Functional characterization of a KCNAB3 genetic epilepsy with febrile seizures plus adult mouse model. Translational pediatrics 0 36345448

Missed literature

Know a paper Affinage missed for KCNAB3? Flag it for the maintainers and the community.

No submissions yet.